By the same authors

Crizotinib for the treatment of previously treated non-small-cell lung cancer associated with an anaplastic lymphoma kinase (ALK) fusion gene: A Single Technology Appraisal.

Research output: Book/ReportCommissioned report

Standard

Crizotinib for the treatment of previously treated non-small-cell lung cancer associated with an anaplastic lymphoma kinase (ALK) fusion gene: A Single Technology Appraisal. / Duarte, Ana Isabel; Burch, Jane Alison; Smith, Alison; Walker, Simon Mark; Fox, Dave; Rodriguez-Lopez, Rocio; Palmer, Stephen John; Eastwood, Alison Jane.

NICE, 2013.

Research output: Book/ReportCommissioned report

Harvard

Duarte, AI, Burch, JA, Smith, A, Walker, SM, Fox, D, Rodriguez-Lopez, R, Palmer, SJ & Eastwood, AJ 2013, Crizotinib for the treatment of previously treated non-small-cell lung cancer associated with an anaplastic lymphoma kinase (ALK) fusion gene: A Single Technology Appraisal. NICE.

APA

Duarte, A. I., Burch, J. A., Smith, A., Walker, S. M., Fox, D., Rodriguez-Lopez, R., ... Eastwood, A. J. (2013). Crizotinib for the treatment of previously treated non-small-cell lung cancer associated with an anaplastic lymphoma kinase (ALK) fusion gene: A Single Technology Appraisal. NICE.

Vancouver

Duarte AI, Burch JA, Smith A, Walker SM, Fox D, Rodriguez-Lopez R et al. Crizotinib for the treatment of previously treated non-small-cell lung cancer associated with an anaplastic lymphoma kinase (ALK) fusion gene: A Single Technology Appraisal. NICE, 2013.

Author

Duarte, Ana Isabel ; Burch, Jane Alison ; Smith, Alison ; Walker, Simon Mark ; Fox, Dave ; Rodriguez-Lopez, Rocio ; Palmer, Stephen John ; Eastwood, Alison Jane. / Crizotinib for the treatment of previously treated non-small-cell lung cancer associated with an anaplastic lymphoma kinase (ALK) fusion gene: A Single Technology Appraisal. NICE, 2013.

Bibtex - Download

@book{113f3c3efb0847478332c37a2d65ccf1,
title = "Crizotinib for the treatment of previously treated non-small-cell lung cancer associated with an anaplastic lymphoma kinase (ALK) fusion gene: A Single Technology Appraisal.",
author = "Duarte, {Ana Isabel} and Burch, {Jane Alison} and Alison Smith and Walker, {Simon Mark} and Dave Fox and Rocio Rodriguez-Lopez and Palmer, {Stephen John} and Eastwood, {Alison Jane}",
year = "2013",
language = "English",
publisher = "NICE",

}

RIS (suitable for import to EndNote) - Download

TY - BOOK

T1 - Crizotinib for the treatment of previously treated non-small-cell lung cancer associated with an anaplastic lymphoma kinase (ALK) fusion gene: A Single Technology Appraisal.

AU - Duarte, Ana Isabel

AU - Burch, Jane Alison

AU - Smith, Alison

AU - Walker, Simon Mark

AU - Fox, Dave

AU - Rodriguez-Lopez, Rocio

AU - Palmer, Stephen John

AU - Eastwood, Alison Jane

PY - 2013

Y1 - 2013

M3 - Commissioned report

BT - Crizotinib for the treatment of previously treated non-small-cell lung cancer associated with an anaplastic lymphoma kinase (ALK) fusion gene: A Single Technology Appraisal.

PB - NICE

ER -